Accounts and Notes Receivable (Tables)

3 Months Ended

Mar. 31, 2025

Accounts and Notes Receivable [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]


(In millions)	March 31, 2025		December 31, 2024		March 31, 2024
Accounts receivable – trade1	$	6,765	$	4,448	$	6,320
Notes receivable – trade1,2	486		167		440
Other3	1,043		1,061		1,146
Total accounts and notes receivable - net	$	8,294	$	5,676	$	7,906

1.Accounts and notes receivable – trade are net of allowances of $190 million, $179 million and $188 million at March 31, 2025, December 31, 2024 and March 31, 2024, respectively.

2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2025, December 31, 2024 and March 31, 2024, there were no significant impairments related to current loan agreements.

3.Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $130 million, $144 million and $125 million as of March 31, 2025, December 31, 2024 and March 31, 2024, respectively.

Accounts Receivable, Allowance for Credit Loss [Table Text Block]


(In millions)
2024
Balance at December 31, 2023	$	205
Net provision for credit losses	13
Other - net of write-offs charged against allowance	(30)
Balance at March 31, 2024	$	188
2025
Balance at December 31, 2024	$	179
Net provision for credit losses	21
Other - net of write-offs charged against allowance	(10)
Balance at March 31, 2025	$	190